On March 25, 2010, Gant, Thomas G.; Shahbaz, Manouchehr M. published a patent.Recommanded Product: 2-Methyl-2-propylpropane-1,3-diol The title of the patent was Preparation of deuterated carisoprodol as carbamate reducers of skeletal muscle tension with improved pharmacokinetics, pharmacodynamics, and toxicity properties. And the patent contained the following:
The present invention relates to novel carisoprodol of formula (I) (wherein R1-R24 are each independently selected from the group consisting of hydrogen and deuterium; and at least one of R1-R24 is deuterium) to be used as new carbamate skeletal muscle relaxants, pharmaceutical compositions thereof, and methods of use thereof. The carisoprodol compounds may be used for the treatment of a skeletal muscle tension-mediated disorder, such as musculoskeletal pain and hypertonia. The experimental process involved the reaction of 2-Methyl-2-propylpropane-1,3-diol(cas: 78-26-2).Recommanded Product: 2-Methyl-2-propylpropane-1,3-diol
The Article related to carisoprodol deuterium derivative preparation skeletal muscle relaxant stability toxicity, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Recommanded Product: 2-Methyl-2-propylpropane-1,3-diol
Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts